ONCOLOGY: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes

Audio Medica News - Medical News Interviews by Audio Medica

Dec 10, 200700:03:52Science & Medicine

Audio Journal of Oncology, December 9th, 2007 Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes PIERRE FENAUX, Pa...

Related Episodes

Continue listening to more episodes from Audio Medica News - Medical News Interviews.

ONCOLOGY: Combinations and Targeted Agents: Better Survival in Mantle Cell Lymphoma

Feb 29, 2008 - 00:06:12

Audio Journal of Oncology, February 26th, 2008 Combinations and Targeted Agents: Better Survival in Mantl...

ONCOLOGY: "Total Therapy" Possible Cure For Multiple Myeloma?

Feb 29, 2008 - 00:05:16

Audio Journal of Oncology, February 26th, 2008 "Total Therapy" Possible Cure For Multiple Myeloma? BART B...

ONCOLOGY: Multiple Myeloma: Towards A Chronic Disease With Cure On The Horizon

Feb 27, 2008 - 00:10:52

Audio Journal of Oncology, February 26th, 2008 Multiple Myeloma: Towards A Chronic Disease With Cure On T...

MEDICINE: Meta-Analysis Proves Statins Help Patients With Diabetes

Jan 11, 2008 - 00:04:52

Audio Journal of Medicine, January 11th, 2008 Meta-Analysis Proves Statins Help Patients With Diabetes CO...

MEDICINE: Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability

Jan 4, 2008 - 00:03:48

Audio Journal of Medicine, January 4th, 2008 Non Drug Intervention: Better Than Antipsychotic Drugs for A...